Back
Brown & Brown, Inc. 10K Form
Sell
20
BRO
Brown & Brown, Inc.
Last Price:
$72.09
Seasonality Move:
8.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | BRO/Brown & Brown, Inc. Quarterly |
| 2023-07-27 | 10Q | BRO/Brown & Brown, Inc. Quarterly |
| 2023-04-28 | 10Q | BRO/Brown & Brown, Inc. Quarterly |
| 2022-11-03 | 10Q | BRO/Brown & Brown, Inc. Quarterly |
| 2022-07-26 | 10Q | BRO/Brown & Brown, Inc. Quarterly |
| 2022-05-09 | 10Q | BRO/Brown & Brown, Inc. Quarterly |
Receive BRO News And Ratings
See the #1 stock for the next 7 days that we like better than BRO
BRO Financial Statistics
Sales & Book Value
| Annual Sales: | $6B |
|---|---|
| Cash Flow: | $424M |
| Price / Cash Flow: | 16.29 |
| Annual Sales: | $37.42 |
| Price / Book: | 1.93 |
Profitability
| EPS (TTM): | 3.19330 |
|---|---|
| Net Income (TTM): | $1.1B |
| Gross Margin: | $5.6B |
| Return on Equity: | 10.58% |
| Return on Assets: | 4.42% |
Brown & Brown, Inc. Earnings Forecast
Key Brown & Brown, Inc. Financial Ratios
-
The Gross Profit Margin over the past 42 years for BRO is 93.84%.
-
The Selling, General & Administrative Expenses for BRO have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 27.84% of Operating Income.
-
The Net Earning history of BRO is 17.91% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 33 years.
Brown & Brown, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | BRO |
| CUSIP: | 115236 |
| Website: | bbrown.com |
Debt
| Debt-to-Equity Ratio: | 0.62 |
|---|---|
| Current Ratio: | 1.04 |
| Quick Ratio: | 0.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.82 |
|---|---|
| Forward P/E Ratio: | 14.48 |
BRO Technical Analysis vs Fundamental Analysis
Sell
20
Brown & Brown, Inc. (BRO)
is a Sell
Is Brown & Brown, Inc. a Buy or a Sell?
-
Brown & Brown, Inc. stock is rated a SellThe current Brown & Brown, Inc. [BRO] share price is $72.10. The Score for BRO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.